Latest Cash Flow News

Noble Helium has received a further unsecured loan of AUD 250,000 from its Executive Chair to support working capital, highlighting management’s confidence amid ongoing refinancing efforts.

Ausgold Limited has delivered an updated Definitive Feasibility Study for its Katanning Gold Project, revealing increased gold production and enhanced financial returns, supported by a $90 million capital raise to accelerate development.

Lunnon Metals has completed a detailed Feasibility Study for its Lady Herial gold deposit, outlining a robust, short-life open pit mine with strong pre-tax cash flows exceeding $40 million. The project is fully permitted and poised for imminent development.

Advanced Braking Technology Ltd reports a robust Q2 FY26 with a 34% increase in product sales revenue and a 191% jump in net profit before tax, underpinned by strong international expansion and domestic contract wins.

Oneview Healthcare reported a stronger cash position in Q4 2025 alongside a key expansion of its US footprint through a new partnership with a Top 10 health system. The company’s strategic moves set the stage for growth in 2026.

Beacon Minerals reported a solid December quarter with 7,310 ounces of gold produced and a 23% rise in realised gold prices, driving revenue to $53.47 million. The company is transitioning mining operations while maintaining strong recovery rates and shareholder returns.

Alcidion Group has been named preferred supplier for a major UK hospital's Electronic Patient Record system, driving a 40% jump in contracted revenue and a robust cash position in Q2 FY26.

Oliver’s Real Food reported a remarkable 1926% increase in EBIT to $527k for the December 2025 quarter, despite a 7.7% revenue decline driven by strategic store closures. Same-store sales rose nearly 6%, underpinning a cautiously optimistic outlook.

Polymetals Resources has resumed operations at its Endeavor Mine following a tragic incident, completing first concentrate shipments and securing $34.4 million in new capital to support exploration and ramp-up.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

Ion Video Limited has completed significant restructuring, strengthened its Melbourne-based tech team, and raised $2.95 million, positioning itself for a technology relaunch in February 2026 with a cash runway extending to mid-2027.

BlueScope announces a $1.00 per share unfranked special dividend, returning $438 million to shareholders from recent asset sales and working capital releases. The steelmaker signals a robust cash flow outlook with a planned capex reduction in FY2027.